108 related articles for article (PubMed ID: 28987606)
1. Design, synthesis and biological evaluation of 4,7,12,12a-tetrahydro-5H-thieno[3',2':3,4]pyrido[1,2-b]isoquinolines as novel adenosine 5'-monophosphate-activated protein kinase (AMPK) indirect activators for the treatment of type 2 diabetes.
Zhou S; Duan Y; Wang J; Zhang J; Sun H; Jiang H; Gu Z; Tong J; Li J; Li J; Liu H
Eur J Med Chem; 2017 Nov; 140():448-464. PubMed ID: 28987606
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and structure-activity relationships of novel 4,7,12,12a-tetrahydro-5H-thieno[3',2':3,4]pyrido[1,2-b]isoquinoline and 5,8,12,12a-tetrahydro-6H-thieno[2',3':4,5]pyrido[2,1-a]isoquinoline derivatives as cellular activators of adenosine 5'-monophosphate-activated protein kinase (AMPK).
Gu Z; Wu L; Duan Y; Wang J; Zhou S; Li J; Chen K; Li J; Liu H
Bioorg Med Chem; 2018 May; 26(8):2017-2027. PubMed ID: 29545016
[TBL] [Abstract][Full Text] [Related]
3. Antidiabetic and antiobesity effects of Ampkinone (6f), a novel small molecule activator of AMP-activated protein kinase.
Oh S; Kim SJ; Hwang JH; Lee HY; Ryu MJ; Park J; Kim SJ; Jo YS; Kim YK; Lee CH; Kweon KR; Shong M; Park SB
J Med Chem; 2010 Oct; 53(20):7405-13. PubMed ID: 20873794
[TBL] [Abstract][Full Text] [Related]
4. Small molecule IVQ, as a prodrug of gluconeogenesis inhibitor QVO, efficiently ameliorates glucose homeostasis in type 2 diabetic mice.
Zhou TT; Zhao T; Ma F; Zhang YN; Jiang J; Ruan Y; Yan QY; Wang GH; Ren J; Guan XW; Guo J; Zhao YH; Ye JM; Hu LH; Chen J; Shen X
Acta Pharmacol Sin; 2019 Sep; 40(9):1193-1204. PubMed ID: 30833709
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activity of novel tiliroside derivants.
Qin N; Li CB; Jin MN; Shi LH; Duan HQ; Niu WY
Eur J Med Chem; 2011 Oct; 46(10):5189-95. PubMed ID: 21856048
[TBL] [Abstract][Full Text] [Related]
6. Berberine treatment prevents cardiac dysfunction and remodeling through activation of 5'-adenosine monophosphate-activated protein kinase in type 2 diabetic rats and in palmitate-induced hypertrophic H9c2 cells.
Chang W; Zhang M; Meng Z; Yu Y; Yao F; Hatch GM; Chen L
Eur J Pharmacol; 2015 Dec; 769():55-63. PubMed ID: 26522928
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of mogrol derivatives as a novel class of AMPKα2β1γ1 activators.
Wang J; Liu J; Xie Z; Li J; Li J; Hu L
Bioorg Med Chem Lett; 2020 Jan; 30(2):126790. PubMed ID: 31744674
[TBL] [Abstract][Full Text] [Related]
8. Antidiabetic activity of perylenequinonoid-rich extract from Shiraia bambusicola in KK-Ay mice with spontaneous type 2 diabetes mellitus.
Huang M; Zhao P; Xiong M; Zhou Q; Zheng S; Ma X; Xu C; Yang J; Yang X; Zhang TC
J Ethnopharmacol; 2016 Sep; 191():71-81. PubMed ID: 27286915
[TBL] [Abstract][Full Text] [Related]
9. Discovery of biaryl-4-carbonitriles as antihyperglycemic agents that may act through AMPK-p38 MAPK pathway.
Goel A; Nag P; Rahuja N; Srivastava R; Chaurasia S; Gautam S; Chandra S; Siddiqi MI; Srivastava AK
Mol Cell Endocrinol; 2014 Aug; 394(1-2):1-12. PubMed ID: 24993155
[TBL] [Abstract][Full Text] [Related]
10. Ginsenoside Compound K suppresses the hepatic gluconeogenesis via activating adenosine-5'monophosphate kinase: A study in vitro and in vivo.
Wei S; Li W; Yu Y; Yao F; A L; Lan X; Guan F; Zhang M; Chen L
Life Sci; 2015 Oct; 139():8-15. PubMed ID: 26285176
[TBL] [Abstract][Full Text] [Related]
11. Towards multi-target antidiabetic agents: Discovery of biphenyl-benzimidazole conjugates as AMPK activators.
Babkov DA; Zhukowskaya ON; Borisov AV; Babkova VA; Sokolova EV; Brigadirova AA; Litvinov RA; Kolodina AA; Morkovnik AS; Sochnev VS; Borodkin GS; Spasov AA
Bioorg Med Chem Lett; 2019 Sep; 29(17):2443-2447. PubMed ID: 31358465
[TBL] [Abstract][Full Text] [Related]
12. Metformin promotes irisin release from murine skeletal muscle independently of AMP-activated protein kinase activation.
Li DJ; Huang F; Lu WJ; Jiang GJ; Deng YP; Shen FM
Acta Physiol (Oxf); 2015 Mar; 213(3):711-21. PubMed ID: 25382002
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and hypoglycemic activity of 9-O-(lipophilic group substituted) berberine derivatives.
Zhang S; Wang X; Yin W; Liu Z; Zhou M; Xiao D; Liu Y; Peng D
Bioorg Med Chem Lett; 2016 Oct; 26(19):4799-4803. PubMed ID: 27561717
[TBL] [Abstract][Full Text] [Related]
14. Salidroside ameliorates insulin resistance through activation of a mitochondria-associated AMPK/PI3K/Akt/GSK3β pathway.
Zheng T; Yang X; Wu D; Xing S; Bian F; Li W; Chi J; Bai X; Wu G; Chen X; Zhang Y; Jin S
Br J Pharmacol; 2015 Jul; 172(13):3284-301. PubMed ID: 25754463
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vitro evaluation of 12-(substituted aminomethyl) berberrubine derivatives as anti-diabetics.
Li R; Wu J; He Y; Hai L; Wu Y
Bioorg Med Chem Lett; 2014 Apr; 24(7):1762-5. PubMed ID: 24613165
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of AMP-activated protein kinase and enhancement of basal glucose uptake in muscle cells by quercetin and quercetin glycosides, active principles of the antidiabetic medicinal plant Vaccinium vitis-idaea.
Eid HM; Martineau LC; Saleem A; Muhammad A; Vallerand D; Benhaddou-Andaloussi A; Nistor L; Afshar A; Arnason JT; Haddad PS
Mol Nutr Food Res; 2010 Jul; 54(7):991-1003. PubMed ID: 20087853
[TBL] [Abstract][Full Text] [Related]
17. Novel mitochondrial complex I inhibitors restore glucose-handling abilities of high-fat fed mice.
Martin DS; Leonard S; Devine R; Redondo C; Kinsella GK; Breen CJ; McEneaney V; Rooney MF; Munsey TS; Porter RK; Sivaprasadarao A; Stephens JC; Findlay JB
J Mol Endocrinol; 2016 Apr; 56(3):261-71. PubMed ID: 26759391
[TBL] [Abstract][Full Text] [Related]
18. X-3, a mangiferin derivative, stimulates AMP-activated protein kinase and reduces hyperglycemia and obesity in db/db mice.
Han J; Yi J; Liang F; Jiang B; Xiao Y; Gao S; Yang N; Hu H; Xie WF; Chen W
Mol Cell Endocrinol; 2015 Apr; 405():63-73. PubMed ID: 25681564
[TBL] [Abstract][Full Text] [Related]
19. Discovery, synthesis, and structure-activity relationships of 20(S)-protopanaxadiol (PPD) derivatives as a novel class of AMPKα2β1γ1 activators.
Liu J; Chen D; Liu P; He M; Li J; Li J; Hu L
Eur J Med Chem; 2014 May; 79():340-9. PubMed ID: 24747289
[TBL] [Abstract][Full Text] [Related]
20. Novel (S)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids: peroxisome proliferator-activated receptor γ selective agonists with protein-tyrosine phosphatase 1B inhibition.
Otake K; Azukizawa S; Fukui M; Kunishiro K; Kamemoto H; Kanda M; Miike T; Kasai M; Shirahase H
Bioorg Med Chem; 2012 Jan; 20(2):1060-75. PubMed ID: 22197396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
